Yu reviewed the benefits and limitations of various electrophysiologic technologies in a diverse group of inflammatory conditions affecting the retina and optic nerve. Ophthalmic electrophysiology is ...

Yehia Hashad, MD, has been appointed to the board of directors and as a member of its science committee for Unity Biotechnology Inc. In the company’s press release 1, Anirvan Ghosh, PhD, chief ...

Chinese investigators found that renal dysfunction is a risk factor associated with the efficacy of intravitreal conbercept (IVC) injections (Lumitin, Chengdu Kanghong Biotech Co., Ltd.) for treating ...

4D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and anti-VEGF-C) from the retina with a single, safe, intravitreal injection.

A total of 43 patients who recovered from the SARS-CoV-2 infection with mild pneumonia were included along with 45 healthy individuals. Researchers from Istanbul, Turkey, conducted a study that found ...

Ramiro Ribeiro, MD, PhD, shares insights from the ongoing research tyrosine kinase inhibitors for AMD and DME.

This database could enhance the workflow of eye care professionals with its in-depth reference data for retinal layer thickness and optic nerve head metrics.

The findings were from 6 patients in the first low-dose cohort of the ongoing first-in-human trial (NCT04627428).

Physicians’ Education Resource (PER) has launched Retina Resource, a comprehensive source of education and information on the latest innovations in anti-VEGF therapy, tailored to retina specialists ...

The data was included in the paper, titled “Sozinibercept Combination Therapy for Neovascular Age-Related Macular ...